Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Don't be quick to peg Merck's Keytruda in second place for NSCLC, analyst says
Don't be quick to peg Merck's Keytruda in second place for NSCLC, analyst says
Don't be quick to peg Merck's Keytruda in second place for NSCLC, analyst says
Submitted by
admin
on September 28, 2015 - 10:15am
Source:
Fierce Pharma Marketing
News Tags:
Merck
Keytruda
non-small cell lung cancer
Bristol-Myers Squibb
Opdivo
Headline:
Don't be quick to peg Merck's Keytruda in second place for NSCLC, analyst says
Do Not Allow Advertisers to Use My Personal information
